#MMR vaccine safe & effective for mass immunisation: encourage use with evidence http://t.co/QHR3UQ4w2L & anecdote http://t.co/W7XYgf6UTA
@mloxton Here for one http://t.co/RIA6yRpW60
@mloxton Because of data like this? http://t.co/RIA6yRpW60 Because #MMR was banned in Japan due to safety concerns.
Because of data like this? http://t.co/RIA6yRpW60 Because #MMR was banned in Japan due to safety concerns. People single vaccines choice too
@mloxton Because of data like this? http://t.co/RIA6yRpW60 Because MMR was banned in Japan due to safety concerns. People want choice.
#MMR vaccine safe & effective for mass immunisation: encourage use with evidence http://t.co/QHR3UQ4w2L & anecdote http://t.co/W7XYgf6UTA
@BBCRadio2 @theJeremyVine There is no reliable data demonstrating safety with MMR. http://t.co/RIA6yRpW60 #MMR #NHS
@Simon4Pinhoe If data cannot be generalised, then it is unreliable & not fit for purpose of evaluating safety of #MMR http://t.co/RIA6yRpW60
@Simon4Pinhoe No this is published scientific research. http://t.co/RIA6yRpW60
@SorchaHolloway 1 problem. Poor quality studies make it difficult to generalise regarding #MMR. http://t.co/RIA6yRpW60
@DJCSouthport 2012 Cochrane summary on MMR lists associations. http://t.co/RIA6yRpW60
@LorraineCakeFan Published peer reviewed scientific evidence led Japan to ban MMR & use singles. 2012 info on MMR http://t.co/SIQjwlgZqh
@DoctorChristian "Single-component measles vaccine (MV)..used in nearly all African WHO member states" (44/47 states) http://t.co/SIQjwlgZqh
"Single-component measles vaccine (MV) ... used in nearly all African WHO member states" (44/47 states) #MMR #NHS http://t.co/SIQjwlgZqh
"The remaining nine were characterised by poor methodological quality" From the Cochrane summary 2012. #MMR http://t.co/SIQjwlgZqh
"Single-component measles vaccine (MV) is actually used in nearly all African WHO member states" (44/47 states) http://t.co/SIQjwlgZqh #MMR
" The remaining nine were characterised by poor methodological quality" From the Cochrane summary 2012. #MMR http://t.co/SIQjwlgZqh
"The methodological quality of many of the included studies made it difficult to generalise their results." #MMR http://t.co/edTHDzL4FD
@martin_lowe @alexdavenport4 I quoted paragraph 5. I guess you didn't read that. What has that to do with your focus http://t.co/edTHDzL4FD
@martin_lowe @alexdavenport4 I quoted paragraph 5. I guess you didn't read that. http://t.co/edTHDzL4FD
@ProfRWinston @DrDeeLord Cochrane summary 2012. http://t.co/edTHDzL4FD
@martin_lowe Cochrane summary lists other diseases. #MMR http://t.co/edTHDzL4FD
List of diseases associated with MMR listed in Cochrane summary 2012. #MMR http://t.co/edTHDzL4FD
@jackjcollins Govt should have offered single vaccines as Japan does. Japan banned #MMR. http://t.co/edTHDzL4FD
(Cochrane) Seguridad y eficacia de la SARUPA http://t.co/0d31zAf8XJ
コクラン共同研究より,MMRワクチンの有用性と副作用に関するシステマティック・レビュー。 / “Vaccines for measles, mumps and rubella in children - The Cochrane …” http://t.co/HsV1OEu7I8
コクラン共同研究より,MMRワクチンの有用性と副作用に関するシステマティック・レビュー。 / “Vaccines for measles, mumps and rubella in children - The Cochrane …” http://t.co/HsV1OEu7I8
コクラン共同研究より,MMRワクチンの有用性と副作用に関するシステマティック・レビュー。 / “Vaccines for measles, mumps and rubella in children - The Cochrane …” http://t.co/HsV1OEu7I8
Vaccines for measles, mumps and rubella in children. http://t.co/6Wq7KkaCRZ
RT @Habakus: Reporting of safety outcomes in MMR vaccine studies, both pre-/post-marketing, "largely inadequate." http://t.co/Su40ULM6
2012 Cochrane Review on safety, efficacy of MMR: "safety outcomes in MMR vaccine studies are largely inadequate" http://t.co/SiJmMKtd #baby
2012 Cochrane Review on safety, efficacy of MMR: "safety outcomes in MMR vaccine studies are largely inadequate" http://t.co/SiJmMKtd #baby
The design & reporting of safety outcomes in MMR vaccine studies, both pre- & post-marketing, are largely inadequate http://t.co/bNZXlqbe
"The design/reporting of safety outcomes in MMR vaccine studies, both pre-/post-marketing, are largely... http://t.co/PChJzoEC
"The design/reporting of safety outcomes in MMR vaccine studies, both pre-/post-marketing, are largely... http://t.co/PWY42RH2
"The design/reporting of safety outcomes in MMR vaccine studies, both pre-/post-marketing, are largely... http://t.co/dx2lqaTs
"The design/reporting of safety outcomes in MMR vaccine studies, both pre-/post-marketing, are largely inadequate." http://t.co/CLTTlm0o
@PureNaturalDiva The evidence against a link between autism and MMR vaccine is pretty overwhelming. http://t.co/1HVO15nm
Vaccines for measles, mumps and rubella in children The Cochrane Library Demicheli Wiley Online Library http://t.co/SGkWcb2Y
MMR vaccine - Cochrane Review - Feb 2012 http://t.co/AqZiCusI "The design and reporting... http://t.co/GTodWTo6
MMR effectiveness. http://t.co/Op4E9HvG
検索して下さったのですね。ありがうございました。@georgebest1969 確かにそういうデータはないですね。基本個別データの集積ですから。http://t.co/kV3TQAe5 ただ、逆にワクチン全部打つことの不利益も示されていません
確かにそういうデータはないですね。基本個別データの集積ですから。http://t.co/OSZOLFUn ただ、逆にワクチン全部打つことの不利益も示されていません。RT @dmburg:
確かにそういうデータはないですね。基本個別データの集積ですから。http://t.co/OSZOLFUn ただ、逆にワクチン全部打つことの不利益も示されていません。RT @dmburg:
Daar gaan we weer... Heb gn last v bep bias: "De meeste studies gedaan met vaccinatie zijn van slechte kwaliteit" http://t.co/OlT7EQXz
RT @secondopinionID: Vaccines for measles, mumps and rubella in children. Demicheli V, et al. 2012. http://t.co/xAiqYoM7
RT @secondopinionID: Vaccines for measles, mumps and rubella in children. Demicheli V, et al. 2012. http://t.co/xAiqYoM7
RT @secondopinionID: Vaccines for measles, mumps and rubella in children. Demicheli V, et al. 2012. http://t.co/xAiqYoM7
Vaccines for measles, mumps and rubella in children. Demicheli V, et al. 2012. http://t.co/xAiqYoM7
no significant association between MMR immunisation and autism http://t.co/ocABuwr8 #vaxfax
Vaccines for measles, mumps and rubella in children - Cochrane Database of Systematic Reviews - Demi http://t.co/sJTGa9h4
The design and reporting of safety outcomes in MMR vaccine studies, both pre- and post-marketing, are largely... http://t.co/XExXHZBV
Cochrane: "design/reporting of safety outcomes in MMR studies, both pre- and post-marketing, are largely inadequate" http://t.co/bV8rf8DE
RT @epidemiorum: RT @elgipi: Vaccines for measles, mumps and rubella in children - The Cochrane Library http://t.co/Cz60DlXT
RT @elgipi: Vaccines for measles, mumps and rubella in children - The Cochrane Library http://t.co/sUQoOkOJ
RT @PediatriaBalear: Vaccines for measles, mumps and rubella in children, Cochrane http://t.co/RDURNQ8f
Vaccines for measles, mumps and rubella in children, Cochrane http://t.co/24IebcHL MMR are serious diseases that can lead to potentially...
RT @angel_h_merino: Vaccines for measles, mumps and rubella in children, Cochrane http://t.co/LIyuXiBj MMR are serious diseases that can lead to potentially...
RT @angel_h_merino: Vaccines for measles, mumps and rubella in children, Cochrane http://t.co/LIyuXiBj MMR are serious diseases that can lead to potentially...
RT @angel_h_merino: Vaccines for measles, mumps and rubella in children, Cochrane http://t.co/LIyuXiBj MMR are serious diseases that can lead to potentially...
RT @Pediatria: RT @elgipi: Vaccines for measles, mumps and rubella in children - The Cochrane Library http://t.co/DolfSeU7
RT @elgipi: Vaccines for measles, mumps and rubella in children - The Cochrane Library http://t.co/sUQoOkOJ
Vaccines for measles, mumps and rubella in children, Cochrane http://t.co/LIyuXiBj MMR are serious diseases that can lead to potentially...
RT @elgipi: Vaccines for measles, mumps and rubella in children - The Cochrane Library http://t.co/sUQoOkOJ
Vaccines for measles, mumps and rubella in children - The Cochrane Library http://t.co/sUQoOkOJ
@davhill Cochrane: http://t.co/i1fi5TEJ ...reporting of safety outcomes in MMR studies, pre- and post-marketing, are largely inadequate.
Combined MMR vaccine: updated #Cochrane summary published Feb 15. http://t.co/IKSQEzar
RT @JayGordonMDFAAP: MMR vaccine. New thoughts from the experts. "Inadequate reporting of safety outcomes" http://t.co/i1fi5TEJ
RT @JayGordonMDFAAP: MMR vaccine. New thoughts from the experts. "Inadequate reporting of safety outcomes" http://t.co/i1fi5TEJ
Vaccines for measles, mumps and rubella in children.: CONCLUSIONS: The design and reporting of safety outcomes i... http://t.co/za0rEC3U
RT @JayGordonMDFAAP: MMR vaccine. New thoughts from the experts. "Inadequate reporting of safety outcomes" http://t.co/i1fi5TEJ
RT @JayGordonMDFAAP: MMR vaccine. New thoughts from the experts. "Inadequate reporting of safety outcomes" http://t.co/i1fi5TEJ
RT @JayGordonMDFAAP: MMR vaccine. New thoughts from the experts. "Inadequate reporting of safety outcomes" http://t.co/i1fi5TEJ
RT @JayGordonMDFAAP: MMR vaccine. New thoughts from the experts. "Inadequate reporting of safety outcomes" http://t.co/i1fi5TEJ
RT @JayGordonMDFAAP: MMR vaccine. New thoughts from the experts. "Inadequate reporting of safety outcomes" http://t.co/i1fi5TEJ
RT @JayGordonMDFAAP: MMR vaccine. New thoughts from the experts. "Inadequate reporting of safety outcomes" http://t.co/i1fi5TEJ
"...vaccine studies are largely inadequate..." http://t.co/IH3yA8V4
2012 research on Mmr vaccine http://t.co/niMjdkuU
RT @JayGordonMDFAAP: MMR vaccine. New thoughts from the experts. "Inadequate reporting of safety outcomes" http://t.co/i1fi5TEJ
MMR vaccine. New thoughts from the experts. "Inadequate reporting of safety outcomes" http://t.co/i1fi5TEJ
Vaccines for measles, mumps and rubella in children.: CONCLUSIONS: The design and reporting of safety outcomes i... http://t.co/ylom1TfI
Vaccines for measles, mumps and rubella in children. http://t.co/f4kjkNNn